BackRecro Pharma Overview

Recro Pharma Net Income

Profitability analysis for REPH.

Quarterly Net Income

-$786000.00
↑ 91.43% YoY

As of Dec 2023

Annual Net Income (TTM)

-$13.27M
↑ 56.13% YoY

Trailing 12 months ending Dec 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin